Highlights:,Merck & Co Inc's experimental treatment, clesrovimab, has demonstrated positive results in a mid- to late-stage ...

First flu-related death of 2024-2025 flu season reported in North Carolina. NCDHHS recommends vaccinations and protective ...

A Charlotte-area man was the first person in North Carolina to die after contracting the flu this season, the N.C. Department of Health and Human Services reported Wednesday.

A new study published in Nature Aging adds to growing evidence that severe infections, including flu, herpes and respiratory tract infections, are linked to accelerated brain atrophy and increased ...

Dairy workers in California continue to face a daunting threat from a virus surge in the state’s dairy cows, as federal ...

The N.C. Department of Health and Human Services is reporting the first flu-related death of the 2024-25 flu season. An adult in the Charlotte metropolitan area died due to complications ...

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over ...

The respiratory syncytial virus (RSV) vaccines were about 80% effective in older adults during the 2023-24 respiratory disease season, which was the first season after the shot was approved in the US, ...

Pfizer's RSV vaccine was 90% effective at preventing the most severe outcomes in the first-ever vaccination season, the ...